Opko Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, m… Read more
Opko Health Inc (OPK) - Net Assets
Latest net assets as of September 2025: $1.31 Billion USD
Based on the latest financial reports, Opko Health Inc (OPK) has net assets worth $1.31 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.00 Billion) and total liabilities ($690.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.31 Billion |
| % of Total Assets | 65.42% |
| Annual Growth Rate | 21.34% |
| 5-Year Change | -18.31% |
| 10-Year Change | -31.03% |
| Growth Volatility | 2912.62 |
Opko Health Inc - Net Assets Trend (1995–2024)
This chart illustrates how Opko Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Opko Health Inc (1995–2024)
The table below shows the annual net assets of Opko Health Inc from 1995 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.37 Billion | -1.71% |
| 2023-12-31 | $1.39 Billion | -11.04% |
| 2022-12-31 | $1.56 Billion | -7.33% |
| 2021-12-31 | $1.69 Billion | +0.81% |
| 2020-12-31 | $1.67 Billion | +3.51% |
| 2019-12-31 | $1.61 Billion | -9.85% |
| 2018-12-31 | $1.79 Billion | -2.84% |
| 2017-12-31 | $1.84 Billion | -11.86% |
| 2016-12-31 | $2.09 Billion | +5.66% |
| 2015-12-31 | $1.98 Billion | +136.87% |
| 2014-12-31 | $835.80 Million | -4.26% |
| 2013-12-31 | $872.98 Million | +329.45% |
| 2012-12-31 | $203.28 Million | +26.35% |
| 2011-12-31 | $160.88 Million | +597.91% |
| 2010-12-31 | $23.05 Million | -60.07% |
| 2009-12-31 | $57.73 Million | +15979.94% |
| 2008-12-31 | $359.00K | -97.86% |
| 2007-12-31 | $16.78 Million | +107.77% |
| 2006-12-31 | $8.08 Million | -7.39% |
| 2005-12-31 | $8.72 Million | -11.28% |
| 2004-12-31 | $9.83 Million | -4.58% |
| 2003-12-31 | $10.30 Million | -35.90% |
| 2002-12-31 | $16.07 Million | -38.46% |
| 2001-12-31 | $26.12 Million | -26.99% |
| 2000-12-31 | $35.77 Million | +1280.21% |
| 1999-12-31 | $2.59 Million | -57.51% |
| 1998-12-31 | $6.10 Million | +454.55% |
| 1997-12-31 | $1.10 Million | -52.17% |
| 1996-12-31 | $2.30 Million | -54.00% |
| 1995-12-31 | $5.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Opko Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 205601000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.01 Million | 0.51% |
| Other Comprehensive Income | $-56.13 Million | -4.11% |
| Other Components | $3.48 Billion | 254.83% |
| Total Equity | $1.37 Billion | 100.00% |
Opko Health Inc Competitors by Market Cap
The table below lists competitors of Opko Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Energy Vault Holdings Inc
NYSE:NRGV
|
$414.16 Million |
|
REGULUS THER.COMPAR DL001
F:7RG0
|
$414.38 Million |
|
Ucap Cloud Information Technology Co Ltd
SHG:688228
|
$414.75 Million |
|
Healthcare Co Ltd
SHG:603313
|
$414.76 Million |
|
Grape King Bio Ltd
TW:1707
|
$413.97 Million |
|
PT Sarana Menara
JK:TOWR
|
$413.86 Million |
|
Logility Supply Chain Solutions, Inc.
NASDAQ:LGTY
|
$413.85 Million |
|
Sihui Fuji Electronics Technology Co Ltd
SHE:300852
|
$413.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Opko Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,389,219,000 to 1,365,448,000, a change of -23,771,000 (-1.7%).
- Net loss of 53,224,000 reduced equity.
- Share repurchases of 90,223,000 reduced equity.
- Other comprehensive income decreased equity by 18,100,000.
- Other factors increased equity by 137,776,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-53.22 Million | -3.9% |
| Share Repurchases | $90.22 Million | -6.61% |
| Other Comprehensive Income | $-18.10 Million | -1.33% |
| Other Changes | $137.78 Million | +10.09% |
| Total Change | $- | -1.71% |
Book Value vs Market Value Analysis
This analysis compares Opko Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.60x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.21x to 0.60x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.98 | $1.19 | x |
| 1996-12-31 | $0.33 | $1.19 | x |
| 1997-12-31 | $0.13 | $1.19 | x |
| 1998-12-31 | $0.63 | $1.19 | x |
| 1999-12-31 | $0.25 | $1.19 | x |
| 2000-12-31 | $2.48 | $1.19 | x |
| 2001-12-31 | $1.66 | $1.19 | x |
| 2002-12-31 | $1.03 | $1.19 | x |
| 2003-12-31 | $0.66 | $1.19 | x |
| 2004-12-31 | $0.61 | $1.19 | x |
| 2005-12-31 | $0.54 | $1.19 | x |
| 2006-12-31 | $0.49 | $1.19 | x |
| 2007-12-31 | $0.13 | $1.19 | x |
| 2008-12-31 | $0.00 | $1.19 | x |
| 2009-12-31 | $0.25 | $1.19 | x |
| 2010-12-31 | $0.09 | $1.19 | x |
| 2011-12-31 | $0.57 | $1.19 | x |
| 2012-12-31 | $0.69 | $1.19 | x |
| 2013-12-31 | $2.47 | $1.19 | x |
| 2014-12-31 | $2.00 | $1.19 | x |
| 2015-12-31 | $3.96 | $1.19 | x |
| 2016-12-31 | $4.17 | $1.19 | x |
| 2017-12-31 | $3.30 | $1.19 | x |
| 2018-12-31 | $3.16 | $1.19 | x |
| 2019-12-31 | $2.71 | $1.19 | x |
| 2020-12-31 | $2.61 | $1.19 | x |
| 2021-12-31 | $2.60 | $1.19 | x |
| 2022-12-31 | $2.17 | $1.19 | x |
| 2023-12-31 | $1.85 | $1.19 | x |
| 2024-12-31 | $1.97 | $1.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Opko Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.46%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.61x
- Recent ROE (-3.90%) is above the historical average (-462.04%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | -54.00% | -2700.00% | 0.02x | 1.30x | $-3.20 Million |
| 1996 | -126.09% | -2900.00% | 0.03x | 1.70x | $-3.13 Million |
| 1997 | -300.00% | -3300.00% | 0.04x | 2.55x | $-3.41 Million |
| 1998 | -44.26% | -225.00% | 0.16x | 1.26x | $-3.31 Million |
| 1999 | -168.09% | -316.87% | 0.31x | 1.73x | $-4.62 Million |
| 2000 | -20.03% | -828.32% | 0.02x | 1.04x | $-10.74 Million |
| 2001 | -33.63% | -659.04% | 0.05x | 1.06x | $-11.40 Million |
| 2002 | -64.44% | -1843.06% | 0.03x | 1.09x | $-11.97 Million |
| 2003 | -56.22% | -44561.54% | 0.00x | 1.10x | $-6.82 Million |
| 2004 | -19.59% | 0.00% | 0.00x | 1.02x | $-2.91 Million |
| 2005 | -2.13% | 0.00% | 0.00x | 1.03x | $-1.06 Million |
| 2006 | -8.02% | 0.00% | 0.00x | 1.08x | $-1.46 Million |
| 2007 | -1599.17% | -31688.90% | 0.02x | 2.36x | $-270.08 Million |
| 2008 | -11095.82% | -421.97% | 0.43x | 60.62x | $-39.87 Million |
| 2009 | -52.16% | -229.05% | 0.15x | 1.51x | $-35.89 Million |
| 2010 | -82.10% | -66.42% | 0.37x | 3.38x | $-21.23 Million |
| 2011 | -0.80% | -4.59% | 0.12x | 1.43x | $-17.37 Million |
| 2012 | -14.26% | -61.75% | 0.16x | 1.42x | $-49.43 Million |
| 2013 | -13.05% | -118.52% | 0.07x | 1.59x | $-202.05 Million |
| 2014 | -20.54% | -188.47% | 0.07x | 1.52x | $-255.28 Million |
| 2015 | -1.52% | -6.10% | 0.18x | 1.41x | $-227.98 Million |
| 2016 | -2.31% | -3.96% | 0.44x | 1.32x | $-257.54 Million |
| 2017 | -16.56% | -31.60% | 0.37x | 1.40x | $-489.61 Million |
| 2018 | -8.54% | -15.45% | 0.40x | 1.37x | $-332.17 Million |
| 2019 | -19.50% | -34.92% | 0.39x | 1.43x | $-476.40 Million |
| 2020 | 1.83% | 2.13% | 0.58x | 1.48x | $-136.57 Million |
| 2021 | -1.79% | -1.70% | 0.74x | 1.42x | $-198.66 Million |
| 2022 | -21.03% | -32.70% | 0.46x | 1.39x | $-484.57 Million |
| 2023 | -13.59% | -21.87% | 0.43x | 1.45x | $-327.78 Million |
| 2024 | -3.90% | -7.46% | 0.32x | 1.61x | $-189.77 Million |
Industry Comparison
This section compares Opko Health Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Opko Health Inc (OPK) | $1.31 Billion | -54.00% | 0.53x | $414.11 Million |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |